Ocular Hypertension trials recruiting in Texas

All Ocular Hypertension trials nationally

Cities in Texas

Recruiting trials in Texas

• A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
  NCT06267274 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
  NCT05401357 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Houston
• Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
  NCT07218783 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · Texas: Houston
• Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
  NCT07218796 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · Texas: San Antonio
• Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
  NCT05844384 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Lackland Air Force Base